Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Timed-Sequential Induction in CBF-AML
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 to 60
Other
P060504
EudraCT N° : 2006-005163-26, NCT00428558
First Published:
10/23/2007
2.
Phase I/II Study of Gemcitabine Hydrochloride, Paclitaxel, Ifosfamide, and Cisplatin as Salvage Chemotherapy in Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
16 to 60
Other
USCTU-UR1002-GEM-TIP
UR1002-Gem-TIP, EU-20769, EUDRACT-2004-004804-19, NCT00551122
3.
Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
60 to 80
Other
C-008
NCT00529880
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute